CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-21 | Ross Douglas T. Former CSO | Grant or award | +213,797 | 234,114 | ||
| 2022-12-16 | Ross Douglas T. Former CSO. | Returned to the company · Option to Purchase Common Stock | −83,334 | 166,666 | ||
| 2022-12-16 | Ross Douglas T. Former CSO. | Returned to the company · Option to Purchase Common Stock | −143,438 | 111,562 | ||
| 2022-12-16 | Ross Douglas T. Former CSO. | Returned to the company · Option to Purchase Common Stock | −100,000 | 0 | ||
| 2022-12-16 | Ross Douglas T. Former CSO. | Returned to the company · Option to Purchase Common Stock | −100,000 | 0 | ||
| 2022-12-01 | Ross Douglas T. Former CSO. | Returned to the company | −150,000 | 20,317 | ||
| 2022-08-15 | Ross Douglas T. Chief Scientific Officer | Grant or award | +150,000 | 170,317 | ||
| 2022-03-25 | Ross Douglas T. Chief Scientific Officer | Purchase | +15,000 | $1.40 | $21K | 20,317 |
| 2022-03-15 | Ross Douglas T. Chief Scientific Officer | Grant or award · Option to Purchase Common Stock | +100,000 | 100,000 | ||
| 2022-03-15 | Ross Douglas T. Chief Scientific Officer | Grant or award · Option to Purchase Common Stock | +100,000 | 100,000 | ||
| 2021-02-25 | Ross Douglas T. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +255,000 | $5.34 | $1.4M | 255,000 |
| 2020-12-11 | Ross Douglas T. CMO | Grant or award | +5,317 | 5,317 |
Page 1 of 1 · 12 trades